Clinical Trial

Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)

Name: Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE) — clinical trial record (NCT07443202)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate lotilaner treatment in patients with ocular rosacea.

Trial Details

NCT Number	NCT07443202
Lead Sponsor	Tarsus Pharmaceuticals, Inc.
Conditions	Ocular Rosacea
Enrollment	155 participants
Start Date	2025-12-05
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-02